Electroencephalographic effects of 3-methyl-5-beta-N-(N'-m-chlorophenyl-piperazino)-ethylpyrazol (EMD-16923) in rabbits.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D003975:Diazepam / Q000494:pharmacology; D004569:Electroencephalography; D006624:Hippocampus / Q000502:physiology; D008032:Limbic System / Q000187:drug effects; D008297:Male; D010775:Photic Stimulation; D010830:Physostigmine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology*; D011720:Pyrazoles / Q000494:pharmacology*; D011817:Rabbits; D013997:Time Factors
D014151:Anti-Anxiety Agents; D010879:Piperazines; D011720:Pyrazoles; D010830:Physostigmine; D003975:Diazepam